Cognitive Behavioral Therapy for Sexual Concerns During Perimenopause: A Four Session Study Protocol

被引:5
作者
Green, Sheryl M. [1 ,2 ]
Furtado, Melissa [2 ,3 ]
机构
[1] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada
[2] St Josephs Healthcare Hamilton, Womens Hlth Concerns Clin, Hamilton, ON, Canada
[3] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada
来源
FRONTIERS IN GLOBAL WOMENS HEALTH | 2021年 / 2卷
关键词
perimenopause; sexual concerns; non-pharmacological management; cognitive behavioral therapy; psychological; PSYCHOMETRIC PROPERTIES; POSTMENOPAUSAL WOMEN; HEALTH SURVEY; INDEX FSFI; MENOPAUSE; SCALE; INTERFERENCE; IMPACT; DESIRE; RELIABILITY;
D O I
10.3389/fgwh.2021.744748
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: During the menopausal transition, women often experience physical (e.g., vasomotor symptoms) and emotional (e.g., anxiety and depression) difficulties that significantly impact functioning and overall quality of life. Although sexual concerns (e.g., decreased sexual desire, orgasm), are reported by up to 87% of peri- and post-menopausal women, and are associated with adverse impact on functioning and distress, treatment options that directly target this area are limited, and most often involve medication (e.g., hormone replacement). Effectiveness of these treatments is often defined as improvements in physical symptoms, however, associated psychological and emotional symptoms rarely, if at all, improve. Cognitive behavioral therapy (CBT) has been proposed as a low-risk treatment for menopausal symptoms with studies showing improvement in frequently reported symptoms (e.g., vasomotor symptoms, depression, anxiety, sleep). Sexual concerns, however, have either not been directly targeted at all in current CBT protocols, or the very few protocols that include sexual concerns, demonstrated modest gains in sexual desire. Methods: This protocol paper outlines the development, design, and implementation of a newly developed CBT for sexual concerns trial during perimenopause (CBT-SC-Peri). Although sexual concerns are prevalent during both the peri- and post-menopausal periods, we will be evaluating the effectiveness of a CBT-SC protocol specifically for perimenopausal women as a means of early intervention. The clinical sample will comprise 82 women aged 40-60 years currently in perimenopause, as per the Stages of Reproductive Aging Workshop (STRAW) definition, and medication stable (if applicable). To ensure participants are experiencing clinically significant sexual concerns, a baseline cut-off score of 26 or lower on the Female Sexual Functioning Index will be utilized. Exclusion criteria include participants with psychotic disorders, or current substance and/or alcohol dependence, or severely depressed/suicidal. The CBT-SC-Peri is a weekly, four session treatment, lasting up to 90min per session and includes psychoeducation and cognitive and behavioral strategies designed to challenge unhelpful beliefs and promote healthy sexual behaviors. As this is an individual CBT protocol, content will be tailored to address the specific problems relevant for each participant. Eligible women will be placed directly into treatment or on a 4-week waitlist and reassessed prior to starting treatment. The primary outcome (sexual satisfaction), as well as secondary outcomes (desire, arousal, relationship satisfaction, body image, vasomotor symptoms, depression, and anxiety) are assessed at baseline, post-waitlist (for those on waitlist), and post-treatment. Discussion: To our knowledge, this will be the first study to investigate the efficacy of a CBT protocol (CBT-SC-Peri) specifically aimed at improving sexual concerns experienced during perimenopause. If effective, this form of treatment may not only be preferred by some, but necessary for others as consumer demand increases for non-pharmacological treatments for perimenopausal symptoms. Further, this protocol can be integrated into perimenopausal care and will be made available by dissemination to healthcare practitioners.
引用
收藏
页数:9
相关论文
共 46 条
[1]   Cognitive-behavioural group intervention for climacteric syndrome [J].
Alder, Judith ;
Besken, Kathrin Eymann ;
Armbruster, Ulrike ;
Decio, Roberta ;
Gairing, Anja ;
Kang, Anjeung ;
Bitzer, Johannes .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2006, 75 (05) :298-303
[2]  
[Anonymous], 2012, HLTH TOP SEX HLTH
[3]   Sleep problems during the menopausal transition: prevalence, impact, and management challenges [J].
Baker, Fiona C. ;
de Zambotti, Massimiliano ;
Colrain, Ian M. ;
Bei, Bei .
NATURE AND SCIENCE OF SLEEP, 2018, 10 :73-95
[4]   Cognitive Behaviour Therapy for Menopausal Hot Flushes and Night Sweats: A Qualitative Analysis of Women's Experiences of Group and Self-Help CBT [J].
Balabanovic, Janet ;
Ayers, Beverley ;
Hunter, Myra S. .
BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2013, 41 (04) :441-457
[5]  
Beck A. T., 1996, BECK DEPRESSION INVE, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]
[6]   Changes in physical symptoms during the menopause transition [J].
Brown, WJ ;
Mishra, GD ;
Dobson, A .
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2002, 9 (01) :53-67
[7]   Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens [J].
Cappelletti, Maurand ;
Wallen, Kim .
HORMONES AND BEHAVIOR, 2016, 78 :178-193
[8]   Validity, cut-points, and minimally important differences for two hot flash-related daily interference scales [J].
Carpenter, Janet S. ;
Bakoyannis, Giorgos ;
Otte, Julie L. ;
Chen, Chen X. ;
Rand, Kevin L. ;
Woods, Nancy ;
Newton, Katherine ;
Joffe, Hadine ;
Manson, JoAnn E. ;
Freeman, Ellen W. ;
Guthrie, Katherine A. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (08) :877-885
[9]   The hot flash related daily interference scale: A tool for assessing the impact of hot flashes on quality of life following breast cancer [J].
Carpenter, JS .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (06) :979-989
[10]   Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence [J].
Collaborative Group on Hormonal Factors in Breast Cancer .
LANCET, 2019, 394 (10204) :1159-1168